In summary, our data support an oncogenic role for COL6A2 in ccRCC and indicate that COL6A2 modulates Wnt/β-catenin signaling in an integrin-dependent manner. This evidence concerns the gene COL6A2 and nonpapillary renal cell carcinoma.